PharmaCyte Biotech Inc (PMCB)

[oldmusky]

Dr Hidalgo, some facts;

" Dr. Hidalgo joined the Johns Hopkins University Kimmel Cancer Center in 2001 where he stayed, as co-director of the drug development program, and GI Programme until 2009. In 2003, Dr. Hidalgo and other colleagues founded the Pancreatic Cancer Research Team (PCRT), a cooperative clinical trials group that focuses on novel Therapeutics for patients with pancreatic cancer. Dr. Hidalgo joined the CNIO in 2009 to lead a Unit in Clinical Research in GI Cancer. Dr. Hidalgo has participated in the clinical development of more than 20 new agents including recently approved drugs such as erlotinib and temsirolimus. He has published more than 160 papers in peer review journals and his work has been funded uninterruptedly by the NCI, AACR, and ASCO and other funding agencies. His most recent efforts focus in novel therapeutic for pancreatic cancer."